[Clear Pathway: the role of bempedoic acid in lipid-lowering strategies. The opinion of cardiologists from Piedmont and Aosta Valley, Italy] [0.03%]
清晰之路：意大利皮埃蒙特和奥斯塔谷地区心脏病专家谈贝美普利酸在降脂策略中的作用及看法
Federico Nardi,Giuseppe Patti,Giorgio Quadri et al.
Federico Nardi et al.
Background: Although international guidelines recommend increasingly lower thresholds for low-density lipoprotein cholesterol (LDL-C), everyday clinical experience shows that many patients fail to reach these targets, exp...
[Modulation of the cholesteryl ester transfer protein: new perspectives for the management of cardiovascular risk] [0.03%]
胆固醇酯转移蛋白的调节：降低心血管风险的新视角
Pietro Scicchitano,Claudio Bilato
Pietro Scicchitano
Despite the widespread use of lipid-lowering therapies, a significant proportion of patients with atherosclerotic cardiovascular disease fail to achieve the recommended LDL-cholesterol targets, thus remaining at high residual risk. Inhibiti...
[Angina in non-obstructive coronary artery disease: some examples from daily practice] [0.03%]
非冠状动脉狭窄性心绞痛的诊断和治疗（经验分享）
Alberto Sarti,Serena Caglioni,Antonio Maria Leone et al.
Alberto Sarti et al.
Angina in non-obstructive coronary artery disease (ANOCA) is a common clinical condition affecting 20-50% of patients undergoing coronary angiography for suspected angina. Despite recent 2024 European guidelines on chronic coronary syndrome...
[Amyloidosis in the elderly: a clinical enigma between frailty and diagnosis] [0.03%]
老年患者的淀粉样变性：诊断与衰弱之间的临床难题
Donatella Del Sindaco,Giovanni Pulignano,Nadia Ingianni et al.
Donatella Del Sindaco et al.
Cardiac amyloidosis is considered a rare disease but is increasingly frequent in elderly patients. In these patients, heterogeneous and peculiar clinical manifestations require specific approaches and dedicated diagnostic-therapeutic pathwa...
[Artificial intelligence in the diagnosis and management of aortic disease: current applications and future directions] [0.03%]
[人工智能在主动脉疾病诊断和管理中的应用及未来发展方向]
Francesco Buia,Luca Bergamaschi,Paola Franceschi et al.
Francesco Buia et al.
Artificial intelligence (AI) is rapidly transforming the field of aortic imaging, enhancing diagnostic accuracy, risk stratification, and treatment planning. This review provides a comprehensive overview of AI applications in measuring aort...
Elisa Soranzo,Laura Munaretto,Gianfranco Sinagra
Elisa Soranzo
[The paradigm shift for beta-blockers after myocardial infarction. Lessons learned from the REBOOT and BETAMI-DANBLOCK trials] [0.03%]
心肌梗死后β受体阻滞剂用药的范式转变——REBOOT和BETAMI-DANBLOCK研究的经验教训
Filippo Ottani,Roberto Latini,Borja Ibanez
Filippo Ottani
[2025 ESC guidelines for the management of cardiovascular disease and pregnancy: what's new?] [0.03%]
[2025年欧洲心脏学会妊娠心血管疾病管理指南的新内容]
Cinzia Perrino,Dario D&#x;Alconzo,Giovanna Geraci
Cinzia Perrino
Antonio Bracco,Marcello Giardina,Livia Bruno et al.
Antonio Bracco et al.
[Residual thrombosis in the left atrial appendage after surgical closure (AtriClip®) in a patient with permanent atrial fibrillation] [0.03%]
永久性心房颤动患者左心耳外科闭合(AtriClip)®)后左心耳残余血栓的超声心动图诊断
Alessandro Esposito,Giuseppe Macca,Paolo Valli et al.
Alessandro Esposito et al.
Atrial fibrillation is one of the main causes of cardioembolic stroke, frequently associated with thrombus formation in the left atrial appendage (LAA). Surgical LAA closure (LAAC) using the AtriClip® device is an effective and guideline-r...